Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cytomegalovirus Infection

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 19 articles: HTML format Text format

Single Articles

January 2019
1. KRISHNA BA, Humby MS, Miller WE, O'Connor CM, et al
   Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.
   Proc Natl Acad Sci U S A. 2019 Jan 15. pii: 1816933116.
   PubMed     Text format     Abstract available
   
   
   December 2018
2. LUGANINI A, Di Nardo G, Munaron L, Gilardi G, et al
   Human cytomegalovirus US21 protein is a viroporin that modulates calcium homeostasis and protects cells against apoptosis.
   Proc Natl Acad Sci U S A. 2018 Dec 10. pii: 1813183115.
   PubMed     Text format     Abstract available
   
   
   October 2018
3. WU K, Oberstein A, Wang W, Shenk T, et al
   Role of PDGF receptor-alpha during human cytomegalovirus entry into fibroblasts.
   Proc Natl Acad Sci U S A. 2018 Oct 1. pii: 1806305115.
   PubMed     Text format     Abstract available
   
   
   September 2018
4. VARDI N, Chaturvedi S, Weinberger LS
   Feedback-mediated signal conversion promotes viral fitness.
   Proc Natl Acad Sci U S A. 2018;115:E8803-E8810.
   PubMed     Text format     Abstract available
   
   
   July 2018
5. SMITHEY MJ, Venturi V, Davenport MP, Buntzman AS, et al
   Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection.
   Proc Natl Acad Sci U S A. 2018 Jul 2. pii: 1719451115.
   PubMed     Text format     Abstract available
   
   
   June 2018
6. SCHLEISS MR
   Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection.
   Proc Natl Acad Sci U S A. 2018 Jun 6. pii: 1806420115.
   PubMed     Text format    
   
   
   April 2018
7. NELSON CS, Huffman T, Jenks JA, Cisneros de la Rosa E, et al
   HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
   Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1800177115.
   PubMed     Text format     Abstract available
   
   
   
8. WANG ECY, Pjechova M, Nightingale K, Vlahava VM, et al
   Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses.
   Proc Natl Acad Sci U S A. 2018 Apr 24. pii: 1720950115.
   PubMed     Text format     Abstract available
   
   
   
9. BARANIAK I, Kropff B, Ambrose L, McIntosh M, et al
   Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
   Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1800224115.
   PubMed     Text format     Abstract available
   
   
   January 2018
10. MOLLER R, Schwarz TM, Noriega VM, Panis M, et al
    miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1719036115.
    PubMed     Text format     Abstract available
    
    
    
11. VAN DER ZWAN A, Bi K, Norwitz ER, Crespo AC, et al
    Mixed signature of activation and dysfunction allows human decidual CD8(+) T cells to provide both tolerance and immunity.
    Proc Natl Acad Sci U S A. 2018;115:385-390.
    PubMed     Text format     Abstract available
    
    
    November 2017
12. CHENG S, Caviness K, Buehler J, Smithey M, et al
    Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency.
    Proc Natl Acad Sci U S A. 2017 Nov 20. pii: 201710522.
    PubMed     Text format     Abstract available
    
    
    September 2017
13. OBERSTEIN A, Shenk T
    Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201710799.
    PubMed     Text format     Abstract available
    
    
    May 2017
14. MURRELL I, Bedford C, Ladell K, Miners KL, et al
    The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus.
    Proc Natl Acad Sci U S A. 2017 May 22. pii: 201704809.
    PubMed     Text format     Abstract available
    
    
    March 2017
15. DALEY-BAUER LP, Roback L, Crosby LN, McCormick AL, et al
    Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways.
    Proc Natl Acad Sci U S A. 2017 Mar 14. pii: 201616829.
    PubMed     Text format     Abstract available
    
    
    February 2017
16. VYSOCHAN A, Sengupta A, Weljie AM, Alwine JC, et al
    ACSS2-mediated acetyl-CoA synthesis from acetate is necessary for human cytomegalovirus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 6. pii: 201614268.
    PubMed     Text format     Abstract available
    
    
    January 2017
17. JENSEN H, Chen SY, Folkersen L, Nolan GP, et al
    EBI3 regulates the NK cell response to mouse cytomegalovirus infection.
    Proc Natl Acad Sci U S A. 2017 Jan 31. pii: 201700231.
    PubMed     Text format     Abstract available
    
    
    November 2016
18. FAN YH, Roy S, Mukhopadhyay R, Kapoor A, et al
    Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.
    Proc Natl Acad Sci U S A. 2016 Nov 16. pii: 201611711.
    PubMed     Text format     Abstract available
    
    
    June 2016
19. DICK JE, Hilterbrand AT, Strawsine LM, Upton JW, et al
    Enzymatically enhanced collisions on ultramicroelectrodes for specific and rapid detection of individual viruses.
    Proc Natl Acad Sci U S A. 2016;113:6403-8.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: